FDA Approves First Treatment for Thyroid Eye Disease

MONDAY, July 6, 2026-- The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).Lumvoa received Breakthrough Therapy Designation and was approved by the FDA under Priority Review...